Phenomenex and USP Offer Workshop on Practical Application of Chapter <621>
News Feb 15, 2010
Phenomenex Inc., a global leader in the manufacture of separation science consumables, announces that it will be teaching a half-day course in conjunction with USP (U.S. Pharmacopeia) Professional Education on the practical application of Chapter <621> to improve HPLC method stability and speed. The course will be offered each day of Pittcon in Room SR-49 at the Orange County Convention Center in Orlando. The fee of $395 ($495 after February 19) includes conferee registration to Pittcon, course materials and refreshments. Course dates and times are:
Monday, March 1 1:00 – 5:00 p.m.
Tuesday, March 2 8:30 – 12:30 p.m.
Wednesday, March 3 1:00 – 5:00 p.m.
Thursday, March 4 8:30 – 12:30 p.m.
USP Chapter <621> defines the adjustments that labs may make to their LC methods without having to revalidate. The course, taught by top technical managers from Phenomenex and senior USP scientists, will use a combination of lecture and small group exercises to teach ways to adjust HPLC methods in various situations while adhering to the Chapter <621> guidelines. The course will be valuable for lab mangers, bench chemists and QA/AC analysts who work with USP monographs for pharmaceuticals and nutraceuticals. Participants may register online at http://www.usp.org/goto/usp621.
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug CandidateNews
Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.READ MORE
Brian Berridge Set to Manage National Toxicology ProgramNews
The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.READ MORE